Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Zimmer Biomet stock
Learn how to easily invest in Zimmer Biomet stock.
Zimmer Biomet Holdings Inc is a medical devices business based in the US. Zimmer Biomet shares (ZBH) are listed on the NYSE and all prices are listed in US Dollars. Zimmer Biomet employs 19,500 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Zimmer Biomet
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ZBH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- ZBH shares summary
- Compare share dealing platforms
- Is ZBH stock a buy or sell?
- Stock performance over time
- Is ZBH suitable for ethical investing?
- Are ZBH shares over-valued?
- Zimmer Biomet's financials
- How volatile are ZBH shares?
- Does Zimmer Biomet pay a dividend?
- Have ZBH shares ever split?
- Other common questions
Zimmer Biomet stock price (NYSE: ZBH)Use our graph to track the performance of ZBH stocks over time.
Zimmer Biomet shares at a glance
|Latest market close||$106.89|
|52-week range||$100.99 - $154.46|
|50-day moving average||$115.91|
|200-day moving average||$124.45|
|Wall St. target price||$130.95|
|Dividend yield||$0.96 (0.89%)|
|Earnings per share (TTM)||$1.34|
Buy Zimmer Biomet shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Zimmer Biomet stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Zimmer Biomet price performance over time
|1 week (2022-06-29)||0.32%|
|1 month (2022-06-03)||-11.39%|
|3 months (2022-04-02)||N/A|
|6 months (2022-01-02)||N/A|
|1 year (2021-07-06)||-34.33%|
|2 years (2020-07-06)||-9.47%|
|3 years (2019-07-05)||117.81|
|5 years (2017-07-06)||121.7824|
Is Zimmer Biomet stock undervalued or overvalued?
Valuing Zimmer Biomet stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zimmer Biomet's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Zimmer Biomet's P/E ratio
Zimmer Biomet's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 80x. In other words, Zimmer Biomet shares trade at around 80x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Zimmer Biomet's PEG ratio
Zimmer Biomet's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.6614. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Zimmer Biomet's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Zimmer Biomet's EBITDA
Zimmer Biomet's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.4 billion.
The EBITDA is a measure of a Zimmer Biomet's overall financial performance and is widely used to measure a its profitability.
Zimmer Biomet financials
|Revenue TTM||$7.9 billion|
|Operating margin TTM||16.47%|
|Gross profit TTM||$5.5 billion|
|Return on assets TTM||3.56%|
|Return on equity TTM||2.31%|
|Market capitalisation||$22.5 billion|
TTM: trailing 12 months
Zimmer Biomet's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Zimmer Biomet.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Zimmer Biomet's total ESG risk score
Total ESG risk: 40.16
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Zimmer Biomet's overall score of 40.16 (as at 12/31/2018) is pretty weak – landing it in it in the 77th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Zimmer Biomet is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Zimmer Biomet's environmental score
Environmental score: 9.29/100
Zimmer Biomet's environmental score of 9.29 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Zimmer Biomet's social score
Social score: 23.4/100
Zimmer Biomet's social score of 23.4 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Zimmer Biomet is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Zimmer Biomet's governance score
Governance score: 16.46/100
Zimmer Biomet's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Zimmer Biomet is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Zimmer Biomet's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Zimmer Biomet scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Zimmer Biomet has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||40.16|
|Total ESG percentile||77.24|
|Environmental score percentile||9|
|Social score percentile||9|
|Governance score percentile||9|
|Level of controversy||2|
Zimmer Biomet share dividends
Dividend payout ratio: 13.01% of net profits
Recently Zimmer Biomet has paid out, on average, around 13.01% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.89% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Zimmer Biomet shareholders could enjoy a 0.89% return on their shares, in the form of dividend payments. In Zimmer Biomet's case, that would currently equate to about $0.96 per share.
While Zimmer Biomet's payout ratio might seem low, this can signify that Zimmer Biomet is investing more in its future growth.
Zimmer Biomet's most recent dividend payout was on 28 July 2022. The latest dividend was paid out to all shareholders who bought their shares by 23 June 2022 (the "ex-dividend date").
Have Zimmer Biomet's shares ever split?
Zimmer Biomet's shares were split on a 103:100 basis on 28 February 2022. So if you had owned 100 shares the day before before the split, the next day you'd have owned 103 shares. This wouldn't directly have changed the overall worth of your Zimmer Biomet shares – just the quantity. However, indirectly, the new 2.9% lower share price could have impacted the market appetite for Zimmer Biomet shares which in turn could have impacted Zimmer Biomet's share price.
Zimmer Biomet share price volatility
Over the last 12 months, Zimmer Biomet's shares have ranged in value from as little as $100.9917 up to $154.4555. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Zimmer Biomet's is 1.1556. This would suggest that Zimmer Biomet's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Zimmer Biomet overview
Zimmer Biomet Holdings, Inc. , together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S. E. T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products.
Zimmer Biomet in the news
The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2022 Financial Results
Zimmer Biomet Announces Creation of Independent 501(c)(3) Movement is Life Coalition
Frequently asked questionsWhat percentage of Zimmer Biomet is owned by insiders or institutions?
Currently 5.48% of Zimmer Biomet shares are held by insiders and 93.222% by institutions. How many people work for Zimmer Biomet?
Latest data suggests 19,500 work at Zimmer Biomet. When does the fiscal year end for Zimmer Biomet?
Zimmer Biomet's fiscal year ends in December. Where is Zimmer Biomet based?
Zimmer Biomet's address is: 345 East Main Street, Warsaw, IN, United States, 46580 What is Zimmer Biomet's ISIN number?
Zimmer Biomet's international securities identification number is: US98956P1021 What is Zimmer Biomet's CUSIP number?
Zimmer Biomet's Committee on Uniform Securities Identification Procedures number is: 98956P102
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert